MedTrace Logo

BIOCLEAN FIRST CARE EX in Combination With Biofinity Lens

NCT02196766 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2020-07-29

Study results available
· View outcomes & findings →

Summary

To determine if patients are unreactive to the lens care solution / Biofinity combination.

Conditions

  • Myopia

Interventions

OTHER

Bioclean First Care EX / comfilcon A

Subjects dispensed Bioclean First Care EX / comfilcon A combination then crossed over to the alternate combination.

OTHER

Aosept Clearcare / comfilcon A

Subjects dispensed Aosept Clearcare / comfilcon A combination then crossed over to the alternate combination.

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Taku Muraoka, OD · Director Professional Services, CVI Japan

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02196766 on ClinicalTrials.gov